North Reading, MA, United States of America

Michael Thomas Finnegan

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 231(Granted Patents)


Location History:

  • North Reading, MA (US) (2017 - 2021)
  • Danvers, MA (US) (2023 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Thomas Finnegan

Introduction

Michael Thomas Finnegan is a notable inventor based in North Reading, MA (US). He has made significant contributions to the field of medical devices, holding a total of 13 patents. His work focuses on improving the functionality and safety of medical equipment, particularly in the area of cannula placement.

Latest Patents

One of Finnegan's latest patents is a medical device designed as a guidewire for cannula placement. This innovative guidewire facilitates the backloading and insertion of a percutaneous pump affixed to a cannula. The design includes a proximal section made of a softer material to minimize damage to the pump during backloading, while the distal section is configured to be stiffer, ensuring precise insertion without compromising the integrity of the guidewire.

Career Highlights

Finnegan is currently employed at Abiomed, Inc., a company renowned for its advancements in heart pump technology. His role at Abiomed has allowed him to leverage his expertise in medical device innovation, contributing to the development of cutting-edge solutions that enhance patient care.

Collaborations

Throughout his career, Finnegan has collaborated with talented individuals such as Zhenghong Tao and Ralph Louis D'Ambrosio. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of innovative medical technologies.

Conclusion

Michael Thomas Finnegan's contributions to the field of medical devices exemplify the impact of innovation on healthcare. His patents and collaborative efforts continue to advance the industry, ultimately improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…